JPY 458.0
(0.44%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 3.44 Billion JPY | -20.71% |
2022 | 4.31 Billion JPY | -6.42% |
2021 | 4.34 Billion JPY | -14.49% |
2020 | 5.36 Billion JPY | -9.24% |
2019 | 5.47 Billion JPY | 23.1% |
2018 | 4.5 Billion JPY | 21.34% |
2017 | 3.63 Billion JPY | -11.94% |
2016 | 4.07 Billion JPY | 12.65% |
2015 | 4.11 Billion JPY | 34.33% |
2014 | 2.9 Billion JPY | -14.29% |
2013 | 3.15 Billion JPY | -4.42% |
2012 | 3.61 Billion JPY | -9.21% |
2011 | 3.96 Billion JPY | -10.97% |
2010 | 4.25 Billion JPY | -9.89% |
2009 | 4.77 Billion JPY | 22.51% |
2008 | 3.93 Billion JPY | 51.05% |
2007 | 4.19 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 972.5 Million JPY | 61.54% |
2023 Q2 | -9 Million JPY | 70.0% |
2023 Q1 | -30 Million JPY | -114.02% |
2023 FY | - JPY | -20.71% |
2023 Q4 | 602 Million JPY | -54.97% |
2023 Q3 | 1.33 Billion JPY | 14955.56% |
2022 FY | - JPY | -6.42% |
2022 Q4 | 214 Million JPY | -47.03% |
2022 Q3 | 404 Million JPY | 129.55% |
2022 Q1 | -41 Million JPY | 41.43% |
2022 Q2 | 176 Million JPY | 529.27% |
2021 Q2 | 249 Million JPY | -51.93% |
2021 Q1 | 518 Million JPY | 5.5% |
2021 FY | - JPY | -14.49% |
2021 Q4 | -70 Million JPY | -111.9% |
2021 Q3 | 588 Million JPY | 136.14% |
2020 Q2 | 487 Million JPY | -33.38% |
2020 Q3 | 480 Million JPY | -1.44% |
2020 FY | - JPY | -9.24% |
2020 Q1 | 731 Million JPY | -23.62% |
2020 Q4 | 491 Million JPY | 2.29% |
2019 Q3 | 812 Million JPY | -0.85% |
2019 Q4 | 957 Million JPY | 17.86% |
2019 FY | - JPY | 23.1% |
2019 Q1 | 236 Million JPY | 36.42% |
2019 Q2 | 819 Million JPY | 247.03% |
2018 Q1 | 127 Million JPY | -11.81% |
2018 Q2 | 559 Million JPY | 340.16% |
2018 Q4 | 173 Million JPY | -81.94% |
2018 Q3 | 958 Million JPY | 71.38% |
2018 FY | - JPY | 21.34% |
2017 Q3 | 410 Million JPY | 89.81% |
2017 Q2 | 216 Million JPY | 22.03% |
2017 Q1 | 177 Million JPY | 105.81% |
2017 FY | - JPY | -11.94% |
2017 Q4 | 144 Million JPY | -64.88% |
2016 Q4 | 86 Million JPY | -88.19% |
2016 FY | - JPY | 12.65% |
2016 Q1 | 240 Million JPY | -16.96% |
2016 Q2 | 523 Million JPY | 117.92% |
2016 Q3 | 728 Million JPY | 39.2% |
2015 Q3 | 562 Million JPY | 18.07% |
2015 FY | - JPY | 34.33% |
2015 Q4 | 289 Million JPY | -48.58% |
2015 Q2 | 476 Million JPY | 2280.0% |
2015 Q1 | 20 Million JPY | 122.47% |
2014 FY | - JPY | -14.29% |
2014 Q1 | -106 Million JPY | -136.55% |
2014 Q2 | 300 Million JPY | 383.02% |
2014 Q4 | -89 Million JPY | -123.48% |
2014 Q3 | 379 Million JPY | 26.33% |
2013 Q1 | 144 Million JPY | 460.0% |
2013 Q2 | 332 Million JPY | 130.56% |
2013 Q3 | 492 Million JPY | 48.19% |
2013 Q4 | 290 Million JPY | -41.06% |
2013 FY | - JPY | -4.42% |
2012 Q1 | 448 Million JPY | 151.69% |
2012 Q2 | 774 Million JPY | 72.77% |
2012 Q3 | 772 Million JPY | -0.26% |
2012 FY | - JPY | -9.21% |
2012 Q4 | -40 Million JPY | -105.18% |
2011 FY | - JPY | -10.97% |
2011 Q1 | 442 Million JPY | -56.67% |
2011 Q2 | 185 Million JPY | -58.14% |
2011 Q4 | 178 Million JPY | -73.11% |
2011 Q3 | 662 Million JPY | 257.84% |
2010 Q2 | 982 Million JPY | -13.86% |
2010 Q3 | 1.39 Billion JPY | 41.85% |
2010 Q4 | 1.02 Billion JPY | -26.78% |
2010 Q1 | 1.14 Billion JPY | -12.24% |
2010 FY | - JPY | -9.89% |
2009 Q3 | 1.53 Billion JPY | 15.91% |
2009 Q4 | 1.29 Billion JPY | -15.48% |
2009 Q2 | 1.32 Billion JPY | 52.24% |
2009 Q1 | 871 Million JPY | -0.0% |
2009 FY | - JPY | 22.51% |
2008 FY | - JPY | 51.05% |
2008 Q4 | 871.02 Million JPY | -25.13% |
2008 Q3 | 1.16 Billion JPY | 61.81% |
2008 Q2 | 719 Million JPY | 0.0% |
2007 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
JINS HOLDINGS Inc. | 10.26 Billion JPY | 66.413% |
Medius Holdings Co., Ltd. | 3.86 Billion JPY | 10.794% |
Ship Healthcare Holdings, Inc. | 31.88 Billion JPY | 89.191% |
JTEC Corporation | 437.18 Million JPY | -688.234% |
Hogy Medical Co.,Ltd. | 10.77 Billion JPY | 68.022% |
Kawamoto Corporation | 944.44 Million JPY | -264.869% |
Terumo Corporation | 219.66 Billion JPY | 98.431% |
KAINOS Laboratories, Inc. | 1.05 Billion JPY | -226.394% |
JAPAN EYEWEAR HOLDINGS CO LTD | 5.18 Billion JPY | 33.513% |
Sysmex Corporation | 115.67 Billion JPY | 97.021% |
Nakanishi Inc. | 32.3 Billion JPY | 89.331% |
Mani, Inc. | 10.69 Billion JPY | 67.791% |
Olympus Corporation | 180.16 Billion JPY | 98.087% |
HOYA Corporation | 260.44 Billion JPY | 98.677% |
SEED Co.,Ltd. | 4.88 Billion JPY | 29.393% |
Asahi Intecc Co., Ltd. | 31.85 Billion JPY | 89.182% |
Medikit Co.,Ltd. | 6.31 Billion JPY | 45.473% |
Daiken Medical Co., Ltd. | 1.65 Billion JPY | -107.912% |
Menicon Co., Ltd. | 16.9 Billion JPY | 79.609% |
Sincere Co., LTD. | 391 Million JPY | -781.33% |
Platz Co., Ltd. | 267.15 Million JPY | -1189.902% |
Paramount Bed Holdings Co., Ltd. | 23.4 Billion JPY | 85.279% |
Shofu Inc. | 5.87 Billion JPY | 41.375% |
Shigematsu Works Co., Ltd. | 1.38 Billion JPY | -148.765% |
Nipro Corporation | 81.2 Billion JPY | 95.757% |
ASO International, Inc. | 602.47 Million JPY | -471.975% |